Listed by the USPTO as PIPIC, ALMA
Tech Center 1700 • Art Units: 1613 1617 1645 1767
This examiner grants 55% of resolved cases
PIPIC, ALMA is assigned to technology center 1700 and art unit 1613. The record includes 726 resolved cases and an allowance rate of 54.8%. The volume supports a meaningful assessment, while the rate reflects a mixed outcome pattern with allowances slightly exceeding non-allowance matters.
The median time to allowance is 1149 days. Interview lift is 54.3%, indicating a strong positive relationship between interviews and allowance. Direct examiner engagement is therefore a particularly important consideration in prosecution planning for this profile.
The recurring companies are L'Oréal, Boston Scientific Corporation, and The Regents of the University of Michigan. The listed firms are BIRCH STEWART KOLASCH & BIRCH, LLP, MARSHALL, GERSTEIN & BORUN LLP, and BALLARD SPAHR LLP. Counsel should combine detailed technical responses with well-prepared interviews and plan for a long path to allowance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18141138 | NANOFIBROUS TISSUE ENGINEERING MATRICES WITH IMPROVED CLINICAL HANDLING PROPERTIES FOR PERIODONTAL AND CRANIOFACIAL REGENERATION AND METHODS OF MAKING THE SAME | Final Rejection | REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18450122 | BIOERODIBLE CROSSLINKING HYDROGEL BASED ON MULTI-ARM POLYOXAZOLINES WITH CAGE-LIKE SILICON-OXYGEN CORES | Non-Final OA | Boston Scientific Scimed, Inc. |
| 17923448 | EMULSIFIER AND EMULSION COMPOSITION CONTAINING SAME | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 17626469 | MULTI-AGENT OCULAR FORMULATIONS AND TREATMENT METHODS | Final Rejection | University of Utah Research Foundation |
| 18412205 | REVERSE THERMAL GELS AND THEIR USE AS VASCULAR EMBOLIC REPAIR AGENTS | Final Rejection | The Regents Of The University Of Colorado, A Body Corporate |
| 17639265 | LIPOSOMAL TROPONOID COMPOUND FORMULATIONS | Non-Final OA | United States Government As Represented By The Department of Veterans Affairs |
| 18775053 | Diagnosis and Treatment of Metabolic Syndrome with Magnesium Compositions | Non-Final OA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
| 18722974 | PHOTODIMERIZABLE POLYMERS COMPRISING AT LEAST ONE POLYOXYALKYLENE GROUP, COMPOSITION COMPRISING SAME AND COSMETIC TREATMENT PROCESS | Non-Final OA | L'Oreal |
| 17962515 | PROCESS FOR ALTERING THE COLOR OF KERATIN FIBERS | Non-Final OA | L'Oreal |
| 17625962 | Herbicidal Mixtures Containing Amine Salts of Acidic Herbicides | Non-Final OA | MONSANTO TECHNOLOGY LLC |
| 18729020 | LIPIDIC COMPOUNDS, AND USES THEREOF | Final Rejection | SANOFI |
| 17753795 | STICKER FORMULATION CONTAINING A SULFOPOLYMER | Final Rejection | Eastman Chemical Company |
| 18851300 | LIPID NANOPARTICLES | Non-Final OA | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY |
| 17619404 | PLANT TREATMENT COMPOSITION | Non-Final OA | Croda International Plc |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy54.8% of resolved applications examined by Alma Pipic were allowed (726 resolved cases), compared with 34.0% across Art Unit 1613 over the last five years.
This examiner's interview lift is +54.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Alma Pipic took 1,149 days on average from filing to allowance.
Alma Pipic examines applications in Art Unit 1613 in Tech Center 1700 (Chemistry & Materials).
